tiprankstipranks
Trending News
More News >
Ironwood Pharma (IRWD)
NASDAQ:IRWD
US Market

Ironwood Pharma (IRWD) Ratios

Compare
311 Followers

Ironwood Pharma Ratios

IRWD's free cash flow for Q1 2025 was $1.00. For the 2025 fiscal year, IRWD's free cash flow was decreased by $ and operating cash flow was $-0.69. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
30.58 0.84 30.58 4.61 15.16
Quick Ratio
30.53 0.84 30.53 4.60 15.16
Cash Ratio
25.71 0.33 25.71 3.84 11.08
Solvency Ratio
0.39 -1.22 0.39 1.02 0.22
Operating Cash Flow Ratio
10.73 0.66 10.73 1.62 5.16
Short-Term Operating Cash Flow Coverage
89.32 0.92 89.32 2.24 53.98
Net Current Asset Value
$ 332.49M$ -584.08M$ 332.49M$ 224.21M$ -759.00K
Leverage Ratios
Debt-to-Assets Ratio
0.38 1.52 0.38 0.42 0.81
Debt-to-Equity Ratio
0.64 -2.07 0.64 0.79 7.24
Debt-to-Capital Ratio
0.39 1.94 0.39 0.44 0.88
Long-Term Debt-to-Capital Ratio
0.38 3.28 0.38 0.36 0.87
Financial Leverage Ratio
1.69 -1.36 1.69 1.86 8.93
Debt Service Coverage Ratio
17.26 -4.56 17.26 3.79 4.27
Interest Coverage Ratio
32.95 -43.71 32.95 7.46 4.85
Debt to Market Cap
0.21 0.39 0.21 0.24 0.24
Interest Debt Per Share
2.74 4.74 2.74 3.12 3.03
Net Debt to EBITDA
-0.92 -0.67 -0.92 -0.62 0.64
Profitability Margins
Gross Profit Margin
99.65%76.33%99.65%99.63%99.19%
EBIT Margin
63.33%44.23%63.33%56.03%35.51%
EBITDA Margin
63.67%-208.90%63.67%56.39%36.43%
Operating Profit Margin
60.97%-213.54%60.97%56.13%36.70%
Pretax Profit Margin
61.48%-214.14%61.48%48.50%27.95%
Net Profit Margin
42.64%-226.37%42.64%127.72%27.26%
Continuous Operations Profit Margin
42.64%-233.00%42.64%127.72%27.26%
Net Income Per EBT
69.35%105.71%69.35%263.36%97.53%
EBT Per EBIT
100.83%100.28%100.83%86.39%76.16%
Return on Assets (ROA)
15.91%-212.76%15.91%46.89%18.99%
Return on Equity (ROE)
26.83%289.42%26.83%87.22%169.50%
Return on Capital Employed (ROCE)
23.29%-484.91%23.29%24.06%27.15%
Return on Invested Capital (ROIC)
16.06%-258.69%16.06%56.36%26.17%
Return on Tangible Assets
15.69%-214.43%15.69%45.90%19.01%
Earnings Yield
9.15%-56.36%9.15%27.93%5.85%
Efficiency Ratios
Receivables Turnover
3.56 3.43 3.56 3.63 3.18
Payables Turnover
2.94 13.38 2.94 1.63 4.74
Inventory Turnover
1.13 0.00 1.13 1.22 3.14M
Fixed Asset Turnover
20.22 24.36 20.22 18.05 15.27
Asset Turnover
0.37 0.94 0.37 0.37 0.70
Working Capital Turnover Ratio
0.61 1.24 0.61 0.79 1.07
Cash Conversion Cycle
300.07 79.18 300.07 176.10 37.71
Days of Sales Outstanding
102.64 106.45 102.64 100.60 114.65
Days of Inventory Outstanding
321.76 0.00 321.76 299.57 <0.01
Days of Payables Outstanding
124.33 27.27 124.33 224.08 76.93
Operating Cycle
424.39 106.45 424.39 400.18 114.65
Cash Flow Ratios
Operating Cash Flow Per Share
1.77 1.18 1.77 1.61 1.06
Free Cash Flow Per Share
1.77 1.18 1.77 1.61 1.05
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 0.99
Dividend Paid and CapEx Coverage Ratio
2.01K 671.89 2.01K 988.28 91.66
Capital Expenditure Coverage Ratio
2.01K 671.89 2.01K 988.28 91.66
Operating Cash Flow Coverage Ratio
0.66 0.26 0.66 0.55 0.37
Operating Cash Flow to Sales Ratio
0.67 0.41 0.67 0.63 0.43
Free Cash Flow Yield
14.31%10.30%14.31%13.83%9.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.93 -1.77 10.93 3.58 17.10
Price-to-Sales (P/S) Ratio
4.66 4.02 4.66 4.57 4.66
Price-to-Book (P/B) Ratio
2.93 -5.13 2.93 3.12 28.99
Price-to-Free Cash Flow (P/FCF) Ratio
6.99 9.71 6.99 7.23 10.87
Price-to-Operating Cash Flow Ratio
6.99 9.69 6.99 7.22 10.76
Price-to-Earnings Growth (PEG) Ratio
-0.17 <0.01 -0.17 <0.01 -0.02
Price-to-Fair Value
2.93 -5.13 2.93 3.12 28.99
Enterprise Value Multiple
6.40 -2.60 6.40 7.49 13.44
Enterprise Value
1.67B 2.40B 1.67B 1.75B 1.91B
EV to EBITDA
6.40 -2.60 6.40 7.49 13.44
EV to Sales
4.07 5.42 4.07 4.22 4.90
EV to Free Cash Flow
6.11 13.11 6.11 6.68 11.42
EV to Operating Cash Flow
6.11 13.09 6.11 6.67 11.30
Tangible Book Value Per Share
4.23 -2.25 4.23 3.73 0.39
Shareholders’ Equity Per Share
4.23 -2.23 4.23 3.73 0.39
Tax and Other Ratios
Effective Tax Rate
0.31 -0.09 0.31 -1.63 0.02
Revenue Per Share
2.66 2.85 2.66 2.55 2.44
Net Income Per Share
1.13 -6.45 1.13 3.26 0.67
Tax Burden
0.69 1.06 0.69 2.63 0.98
Interest Burden
0.97 -4.84 0.97 0.87 0.79
Research & Development to Revenue
0.11 0.26 0.11 0.17 0.23
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.07 0.07 0.07 0.05 0.08
Income Quality
1.56 -0.18 1.56 0.50 1.59
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis